Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Mar 29, 2022 2:19am
356 Views
Post# 34554326

RE:1y ago: The launch of the Anti-Cancer Therapy Research

RE:1y ago: The launch of the Anti-Cancer Therapy ResearchWell said...re: your following comment:

"TLT's technology has the ability to save bladders, avoid 6-7 hour life-threatening surgeries, restore quality of life (QOL), an important indicator that all specialists always look at."

I agree...QOL is ultimately the most important measure of treatment success for both patients & docs.  With FDA approval, I would hope our esteemed physicians on the MSAB will champion this new PDT/PDC approach at their respective institutions.  Such physician leaders can play a significant role in getting community specialists to adopt new treatment technologies via their participation/influence with the AUA in the formation of new treatment guidelines/standards of care.  Actively participating in the teaching/training of future specialists can also play an important role, & Dr. Kamat has been recognized as one of the best to do just that.  TLT will just need to pass him the torch...JMO.  Good luck...
<< Previous
Bullboard Posts
Next >>